Stargardt Disease

What happens in Stargardt disease

The retina's light-sensing cells (photoreceptors) constantly recycle vitamin A derivatives to detect light. The ABCA4 protein clears a by-product of this cycle. When ABCA4 does not work, toxic waste called lipofuscin (including a compound known as A2E) builds up in the retinal pigment epithelium, the support layer beneath the photoreceptors. Over time, these support cells die and the photoreceptors above them follow, mainly in the macula.

On examination, doctors see yellow-white flecks around the macula and, later, an oval area of thinning (atrophy) that can look like "beaten bronze".

Symptoms

• Blurry or distorted central vision: usually the first symptom, often in both eyes.
• Difficulty reading and recognizing faces.
• Gray, black or hazy spots in the center of vision.
• Slow dark adaptation: taking longer to see when moving into dim light.
• Light sensitivity and glare.
• Reduced color vision in later stages.
• Side vision usually stays normal, so people can generally walk around independently.

In children, an early sign may be poor vision on a school screening that glasses cannot fully correct, sometimes before any changes are visible in the retina. This can lead to children being wrongly suspected of exaggerating their symptoms.

Stargardt disease vs age-related macular degeneration

Both damage central vision. See macular degeneration for the age-related forms.

Causes and inheritance

• ABCA4 (STGD1): the cause in most people. Inherited in an autosomal recessive pattern: both parents carry one changed copy, usually without symptoms. Each child of two carrier parents has a 1 in 4 chance of having the disease, a 1 in 2 chance of being a carrier, and a 1 in 4 chance of neither.
• ELOVL4 (STGD3) and PROM1 (STGD4): rarer dominant forms, where one affected parent can pass it on with a 1 in 2 chance.

Different ABCA4 variants explain why the disease ranges from severe childhood forms to mild late-onset forms that preserve the very center of vision.

How Stargardt disease is diagnosed

• Dilated eye exam: yellow flecks and macular changes.
• Fundus autofluorescence: shows lipofuscin as bright flecks and atrophy as dark areas. It is very useful for diagnosis and monitoring.
• Optical coherence tomography (OCT): detailed cross-sections showing thinning of retinal layers.
• Electroretinogram (ERG): measures retinal function and helps predict how widespread the disease will be.
• Visual field and color vision testing.
• Genetic testing: confirms the diagnosis, guides family counseling and is required to join gene-specific trials.

Treatment and management

There is currently no FDA-approved treatment that stops Stargardt disease. Management focuses on protecting the retina and making the most of remaining vision.

Protect the retina

• Avoid vitamin A supplements: high-dose vitamin A, and supplements containing it (including some eye vitamins and AREDS-type formulas with beta-carotene), may speed lipofuscin build-up. A normal diet with ordinary amounts of vitamin A is fine; you do not need to avoid vegetables.
• UV and bright light protection: wear sunglasses that block UV and reduce blue light, and a brimmed hat outdoors.
• Do not smoke, and avoid secondhand smoke.

Low-vision support

Low-vision services make a large difference:

• magnifiers, large print and high-contrast settings
• screen readers, text-to-speech and smartphone magnifier apps
• telescopes for distance and electronic magnifiers
• training to use eccentric viewing, looking slightly off-center to use healthier retina
• school accommodations (front seating, enlarged materials, extra time) and workplace adaptations

Clinical trials

Researchers are testing drugs that slow the vitamin A cycle or reduce toxic by-products (such as deuterated vitamin A and visual cycle modulators), gene therapies, stem cell treatments and optogenetics. The National Eye Institute and Foundation Fighting Blindness list current trials.

Outlook

Stargardt disease progresses slowly. Many people reach a central vision of about 20/200 (legal blindness in the US) over years, but rarely become totally blind, because side vision is usually kept. Onset in childhood often means faster progression; later onset is usually milder. Most people continue to work, study and live independently, and many cannot drive because of central vision requirements.

Frequently asked questions

What are the first signs of Stargardt disease?

The first signs are usually blurry or distorted central vision in both eyes, often noticed in childhood or the teenage years as difficulty reading, seeing the board, or recognizing faces. Some people notice slow adjustment to dim light or a new sensitivity to glare.

Does Stargardt disease cause total blindness?

Rarely. Stargardt disease mainly destroys central vision, so reading and recognizing faces become difficult, and many people become legally blind. Peripheral vision usually stays, so most people can still move around independently and use low-vision aids.

Is Stargardt disease genetic?

Yes. It is usually caused by variants in both copies of the ABCA4 gene, inherited from two carrier parents. Siblings of an affected person have a 1 in 4 chance of being affected. Rarer dominant forms can pass directly from an affected parent to a child.

Should people with Stargardt disease avoid vitamin A?

Yes, they are usually advised to avoid vitamin A supplements, including eye vitamins containing vitamin A or beta-carotene, because extra vitamin A may speed the build-up of toxic waste in the retina. Eating a normal, balanced diet is fine.

Is there a cure for Stargardt disease?

Not yet. There is no approved treatment that stops or reverses it. Several drugs, gene therapies and cell therapies are being tested in clinical trials. In the meantime, light protection, avoiding vitamin A supplements and low-vision rehabilitation help preserve function.